03 May 2007 - Dyax Corp. announced that the United States Patent and Trademark office issued U.S. Patent No. 7,208,293, Dyax's seventh U.S. patent covering its proprietary protein display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting binding proteins, such as antibodies, through the use of eukaryotic cell surface display. In addition to its seven U.S. patents, Dyax holds several issued patents for phage display in Canada, Israel, and Japan, with pending applications in other countries.
"This newly issued patent strengthens Dyax's already dominant patent portfolio position in the field of protein display," stated Dr. Ivana Magovcevic-Liebisch, Dyax's General Counsel and Executive Vice President of Administration. "Our broad technology platform continues to provide Dyax and our collaborators with the ability to develop novel compounds through both phage and yeast display."
 |
www.bionity.com/news/e/64314 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/64314 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |